Cambridge Cancer Genomics uses liquid biopsies and AI to outrun cancer

Making liquid biopsy and artificial intelligence technologies work together could help doctors make faster decisions to treat cancer on time. Philip talked to the CEO of Cambridge Cancer Genomics to find out what this approach can mean for the treatment of cancer. Although much progress has been made in recent years, cancer remains one of the most dreaded diagnosis. For many types of cancer, current treatment options only alleviate symptoms or stop working after a while, only delaying the inevitable for a few months. One of the biggest challenges to treating cancer is its ability to rapidly mutate.